Paradigm Biocapital Advisors’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,950,327
Closed -$18.2M 36
2023
Q2
$18.2M Buy
1,950,327
+445,000
+30% +$4.15M 1.41% 28
2023
Q1
$13.4M Buy
+1,505,327
New +$13.4M 1.27% 23